-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

623. Mantle Cell, Follicular, Waldenstrom’s, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological: Poster III

Symposia: Mantle Cell, Follicular, Waldenstrom’s, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Monday, December 9, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Loretta Nastoupil1*, Saurabh Dahiya, MD, FACP2*, Maria Lia Palomba, MD3, Alejandro Martín García-Sancho4*, Juan Luis Reguera, MD5*, John Kuruvilla, MD, FRCPC6, Ulrich Jaeger, MD7, Guillaume Cartron, MD, PhD8*, Koji Izutsu, MD, PhD9, Martin Dreyling, MD10, Brad S. Kahl, MD11, Herve Ghesquieres, MD, PhD12*, Kirit Ardeshna, MD, MA, FRCP13*, Hideki Goto, MD, PhD14*, Anna Maria Barbui, MD15*, Jeremy S. Abramson, MD16, Peter Borchmann, MD17, Isabelle Fleury, MD, MSc18, Stephan Mielke, MD19, Alan P Skarbnik, MD20, Manali Kamdar, MD, MBBS21*, Reem Karmali, MD22, Andreas Viardot, MD, PhD23, Thalia Farazi, MD, PhD24, Grace Shih Hui Kao, MD25, Min Vedal, PhD26*, Rina Nishii, PhD27*, Jessica Papuga, PhD26*, Jinender Kumar, MS27* and Franck Morschhauser, MD, PhD28

1The University of Texas MD Anderson Cancer Center, Houston, TX
2Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA
3Memorial Sloan Kettering Cancer Center, New York, NY
4Hospital Universitario de Salamanca, IBSAL, CIBERONC, Universidad de Salamanca, Salamanca, Spain
5Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS) / CSIC, Universidad de Sevilla, Seville, Spain
6Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
7Medical University of Vienna, Vienna, Austria
8Montpellier University Hospital Center, UMR CNRS 5535, Montpellier, France
9National Cancer Center Hospital, Tokyo, Japan
10Medizinische Klinik III, Klinikum der Universität, LMU München, München, Germany
11Washington University School of Medicine in St. Louis, St. Louis, MO
12Hôpital Lyon Sud, Lyon, France
13University College London Hospitals NHS Foundation Trust, London, United Kingdom
14Department of Hematology, Hokkaido University Hospital, Sapporo, Japan
15Azienda Socio Sanitaria Terriroriale Papa Giovanni XXIII, Bergamo, Italy
16Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA
17Universität zu Köln, Köln, Germany
18Hôpital Maisonneuve – Rosemont, Montreal, ON, Canada
19Karolinska Institutet and University Hospital; Karolinska Comprehensive Cancer Center, Karolinska ATMP Center, Stockholm, Sweden
20Novant Health Cancer Institute, Charlotte, NC
21University of Colorado Cancer Center, Aurora, CO
22Northwestern University Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL
23University Hospital, Ulm, Germany
24Bristol Myers Squibb, San Francisco, CA
25Bristol Myers Squibb, Cambridge, MA
26Bristol Myers Squibb, Boudry, Switzerland
27Bristol Myers Squibb, Princeton, NJ
28Centre Hospitalier Universitaire de Lille, Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille, France

Michael Wang, MD1, Andre Goy, MD, MS2, Javier Munoz, MD3,4*, Frederick L. Locke, MD5, Caron A. Jacobson, MD, MMSc6, Brian T. Hill, MD, PhD7, John Timmerman, MD8, Ian W. Flinn, MD, PhD9, David B. Miklos, MD, PhD10, John M. Pagel, MD, Ph.D, DSc11, Marie José Kersten, MD, PhD12*, Edouard Forcade, MD, PhD13*, Max S. Topp14*, Roch Houot, MD, PhD15*, Amer Beitinjaneh, MD16*, Dan Zheng, PhD17*, Mengru Chang, MSc17*, Rhine Shen, PhD17*, Wangshu Zhang, PhD17*, Rita Damico Khalid, DO17*, Ioana Kloos, MD, FRCPC17* and Patrick M. Reagan, MD18

1The University of Texas MD Anderson Cancer Center, Houston, TX
2John Theurer Cancer Center, Hackensack, NJ
3Mayo Clinic, Phoenix, AZ
4Banner MD Anderson Cancer Center, Gilbert, AZ
5Moffit Cancer Center, Tampa, FL
6Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
7Cleveland Clinic Foundation, Cleveland, OH
8UCLA David Geffen School of Medicine, Los Angeles, CA
9Tennessee Oncology & OneOncology, Nashville, TN
10Stanford University, Stanford, CA
11Swedish Cancer Institute, Seattle, WA
12Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands
13Service d'Hématologie Clinique et Thérapie Cellulaire, CHU Bordeaux, Bordeaux, France
14Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany
15CHU Rennes, Univ Rennes, Inserm & EFS, Rennes, France
16University of Miami, Miami, FL
17Kite, a Gilead Company, Santa Monica, CA
18University of Rochester School of Medicine, Rochester, NY

Manasawee Tanariyakul1*, Sakditad Saowapa, MD2, Akihiro Miyashita, MD1*, Chalothorn Wannaphut, MD1, Panisara Fangsaard, MD3* and Kensuke Takaoka, M.D., MSc, PhD1*

1Department of Internal Medicine, University of Hawaii John A.Burns School of Medicine, Honolulu, HI
2Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX
3Department of Internal Medicine, Bassett Medical Center, Cooperstown, NY

Irene Dogliotti, MD1*, Cristina Jimenez, PhD2*, Veronica Peri3*, Martina Ferrante, PhD4*, Davide Musto5*, Silvio Mercadante, PhD5*, Gian Maria Zaccaria, PhD6*, Marco Ghislieri, PhD7*, Giulia Benevolo, MD4*, Enrique M. Ocio8, Araceli Rubio, MD9*, Ilda Maria Murillo, MD9*, Fernando Escalante10*, Carmen Aguilera, MD11*, Aránzazu García Mateo, PhD12*, Alfonso Garcia de Coca13*, Roberto Hernandez14*, Julio Dávila-Valls15*, Federica Cavallo3*, Noemi Puig, PhD16, Almudena Navarro Bailon, MD17*, Veronica Gonzalez-Calle, MD, PhD18*, Maria Eugenia Sarasquete, PhD18*, Miguel Alcoceba, PhD19*, Simone Ragaini4*, Michele Clerico4*, Chiara Consoli, MD3*, Maria Garcia Alvarez, PhD18*, Carmen Chillon, MD18*, Alejandro Medina, PhD18*, Marcos Gonzalez Diaz, MD18*, Norma C. Gutierrez20*, Benedetto Bruno, MD, PhD4, Daniela Drandi4*, Simone Ferrero, MD21 and Ramon García-Sanz, MD, PhD18

1Division of Hematology, AOU Città della Salute e della Scienza di Torino, Torino, Italy
2Haematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca (IBSAL), CIBERONC and Center for Cancer Research-IBMCC (USAL-CSIC), Salamanca, ESP
3Hematology Division I, Department of Molecular Biotechnologies and Health Sciences, University of Turin/University Hospital A.O.U. “Città della Salute e della Scienza”, Turin, Italy
4Division of Hematology 1, Department of Biotechnology and Health Sciences, University of Torino, Torino, Italy
5Division of Hematology 1, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy
6Department of Electrical and Information Engineering (DEI), Polytechnic University of Bari, Bari, Italy
7Department of Electronics and Telecommunications, Politecnico di Torino, Turin, 10129, Italy and PolitoBIOMed Lab, Politecnico di Torino, Torino, Italy
8Hospital Universitario Marqués de Valdecilla (IDIVAL), Universidad de Cantabria, Santander, Spain
9Hematology Department, Hospital Miguel Servet, Zaragoza, Spain
10Hospital Universitario de Leon, Leon, Spain
11Hematology Department, Regional Hospital of El Bierzo, Leon, Spain
12Department of Hematology, Hospital General de Segovia, Segovia, Spain
13Department of Hematology, Clinical Hospital of Valladolid, Valladolid, Spain
14Hematology Department, Hospital Virgen de la Concha, Zamora, Spain
15Hospital Universitario Nuestra Senora de Sonsoles, Avila, ESP
16Hospital Universitario de Salamanca (HUSAL), IBSAL, IBMCC (USAL-CSIC), CIBERONC, Salamanca, Spain
17Hospital Universitario de Salamanca, Salamanca, Spain
18Haematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca (IBSAL), CIBERONC and Center for Cancer Research-IBMCC (USAL-CSIC), Salamanca, Spain
19Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Center of Salamanca-IBMCC (USAL-CSIC), Salamanca, Spain
20Institute of Biomedical Research of Salamanca (IBSAL), University Hospital, Salamanca, Spain
21Department of Molecular Biotechnology and Health Sciences, Hematology Division, University of Torino, Torino, TO, Italy

Guifang Ouyang1*, Lixia Sheng1*, Jiaping Wang1*, Hui Zeng2*, Shanhao Tang1*, Xibin Xiao3*, Yamin Tan4*, Qunyi Guo5*, Yanping Shao5*, Minchao Yan2* and Wenbin Qian3

1Department of Hematology, The First Affiliated Hospital of Ningbo University, Ningbo, China
2Department of Hematology, the First Affiliated Hospital of Jiaxing University, Jiaxing, China
3Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
4Zhejiang Cancer Hospital, Hangzhou, China
5Department of Hematology,Taizhou Hospital Of Zhejiang Province, Taizhou, China

Muhammad Junaid Tariq, MBBS1, Kristopher Attwood, PhD, MS2*, Andrea Carolina Anampa-Guzmán, MD1*, Showkat Hamid, MD1, Alex Niu, MD3*, David Kaldas, MD4, Shrinjaya B Thapa, MD5, Jessica Leng6*, Youssef Youssef, MD7, Keegan Carroll8*, Rachel Treitman, BS9*, Abdul Rafae, MD, MBBS10, Sachi Singhal, MD, MBBS11*, Shazia K. Nakhoda, MD12*, Samer Al Hadidi, MD, MSc10, Steven M. Bair, MD13, Timothy Voorhees, MD, MSc14, Narendranath Epperla, MD, MS15, Paolo F. Caimi16, Ariel F. Grajales-Cruz, MD17, Francisco Hernandez-Ilizaliturri, MD18 and Matthew J Cortese, MD, MPH19

1Roswell Park Comprehensive Cancer Center, Buffalo, NY
2Department of Biostatistics, Roswell Park Comprehensive Cancer Center, Buffalo, NY
3Department of Medicine (Lymphoma Section), Roswell Park Comprehensive Cancer Center, Buffalo, NY
4Moffitt Cancer Center, Tampa, FL
5H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
6School of Medicine, Case Western Reserve University, Cleveland, OH
7The Ohio State University, Columbus, OH
8Division of Hematology, University of Colorado School of Medicine, Aurora, CO
9University of Colorado School of Medicine, Denver, CO
10University of Arkansas for Medical Sciences, Little Rock, AR
11Hematology/Oncology, Temple University/Fox Chase Cancer Center, Upland, PA
12Fox Chase Cancer Center, Philadelphia, PA
13Division of Hematology, University of Colorado - Anschutz, Denver, CO
14Division of Hematology, The Ohio State University, Columbus, OH
15James Comprehensive Cancer Center, The Ohio State University, Columbus, OH
16Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
17H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
18Roswell Park Comprehensive Cancer Center, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY
19Roswell Park Comprehensive Cancer Center, Department of Medicine (Lymphoma Section), Buffalo, NY

Zachary D. Epstein-Peterson, MD1,2, Christine E. Ryan, MD3, Sean M. Devlin, PhD4*, Noa Golan Accav5*, Abraham Avigdor, MD6, Magdalena Corona, MD, PhD7*, Ivetta Danylesko, MD8*, Jamie Dela Cruz9*, Andre Goy, MD, MS10,11, Caron A. Jacobson, MD, MMSc3, Ofrat Beyar Katz12, Hazim Khatib, MD12*, Anita Kumar, MD13, Lori A. Leslie, MD14, Alejandro Luna, MD, PhD15*, Ronit Marcus, MD16*, Reid W. Merryman, MD17, Miguel Angel Perales, MD18,19, Alfredo Rivas-Delgado, MD, PhD2, Gilles Salles, MD, PhD1,20, Michael Scordo, MD1,21, Inbal Sdayoor, BSc22*, Gunjan L. Shah, MD1,23, Noga Shem-Tov, MD22*, Avichai Shimoni, MD24*, Nataly Vahaba12*, Ronit Yerushalmi, MD22, Andrew D. Zelenetz, MD, PhD2, Maria Lia Palomba, MD2,18, Andrew Ip, MD, MSc10 and Roni Shouval, MD, PhD7,25

1Department of Medicine, Weill Cornell Medical College, New York, NY
2Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
3Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
4Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
5Institute of Hematology, Sheba Medical Center, Ramat Gan, Israel
6Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Ramat Gan, Israel
7Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
8Division of Hematology and Bone Marrow Transplantation, Sheba Medical Center, Ramat Gan, Israel
9Dana Farber Cancer Institute, Boston, MA
10Lymphoma Division, John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ
11John Theurer Cancer Center, Hackensack, NJ
12Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
13Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Short Hills, NJ
14Lymphoma Division, John Theurer Cancer Center, Hackensack Meridian School of Medicine, Hackensack, NJ
15Unidad de trasplante y terapia celular, Hospital Universitario Ramon y Cajal, Madrid, Spain
16School of Medicine, Faculty of Medical and health Sciences,Aviv University, Tel Aviv, Israel
17Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
18Department of Medicine, Weill Cornell Medical College, New York
19Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
20Lymphoma Service Chief, Memorial Sloan Kettering Cancer Center, New York, NY
21Transplant and Cellular Therapy Services, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, NY
22Division of Hematology and Bone Marrow Transplantation, The Chaim Sheba Medical Center, Ramat Gan, Israel
23Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY
24Division of Hematology and Bone Marrow Transplantation Department, Chaim Sheba Medical Center, Tel-Aviv, Israel
25Department of Medicine, Weill Cornell Medicine, New York, NY

Alexander Grunenberg, MD1*, Birgit Schmelze2*, Jaqueline Gökeler3*, Heike Mund2*, Andreas Viardot, MD, PhD1, Jens Dreyhaupt4*, Gabriele Nagel5*, Marcel Reiser, MD6*, Thomas Gabrysiak7*, Friederike Braulke8*, Juergen Dunst9*, Rudolf Schlag, MD10*, Tobias Gaska, MD11, Volker Runde12*, Doris Kramer13*, Thomas Weber14*, Lothar Müller, MD15*, Patricia Johansson, MD16*, Carsten Ziske17*, Georg Hess, MD18* and Christian Buske, MD2

1Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
2Institute of Experimental Cancer Research, University Hospital Ulm, Ulm, Germany
3University Hospital Ulm, Ulm, Germany
4Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany
5University of Ulm, Ulm, Germany
6Praxis für internistische Onkologie und Hämatologie (PIOH), Frechen, Germany
7Onkologisches Zentrum, Wolfsburg-Helmstedt, Germany, Wolfsburg, Germany
8University Medical Center Goettingen, Goettingen, DEU
9Department of Radiotherapy, University Hospital Kiel, Kiel, Germany
10Practice for Hematology and Oncology Wuerzburg, Wuerzburg, Germany
11Brüderkrankenhaus St. Josef, Paderborn, Germany
12Wilhelm-anton-Hospital, Goch, Germany
13Kath. Krankenhaus Hagen gem. GmbH, St.-Josefs-Hospital Hagen, Hagen, Germany
14Department of Internal Medicine IV, Haematology and Oncology, University Hospital Halle (Saale), Martin-Luther-University Halle-Wittenberg, Halle, Germany
15Praxis Leer, Onkologie UnterEms, Leer, Leer, Germany
16Department of Haematology, University Hospital Essen, Essen, Germany
17St. Josef-Hospital Troisdorf, Practice Network Hematology and Intern. Oncology, Troisdorf,, Troisdorf, Germany
18University Clinic Mainz, Mainz, Germany

Jose C. Villasboas Bisneto, MD1, Stephen D. Smith, MD2, Danielle S Wallace, MD3, Jean Pierre Marolleau, MD4, Carlos Grande Garcia, MD PhD5*, Reid W. Merryman, MD6, Francesc Bosch, MD, PhD7, Luca Arcaini, MD8*, Antonio Pinto9*, Norma C. Gutierrez10*, Brian G. Till, MD11, Pierre Morel, MD, PhD4*, Rocío Figueroa Mora, MD, PhD5*, Cristina García, MD7*, Sara Rattotti, MD8*, Lucie Aubergeon, PhD12*, Laurent Chêne, PhD12*, Jan Fagerberg, MD, PhD12, Pier Luigi Zinzani, MD, PhD13, Philippe Armand, MD, PhD6, Jonathan W. Friedberg, MD14 and Stephen M. Ansell, MD, PhD1

1Mayo Clinic, Rochester, MN
2Fred Hutchinson Cancer Center, Seattle, WA
3Wilmot Cancer Institute, University of Rochester, Rochester, NY
4Centre Hospitalier Universitaire Amiens-Picardie, Amiens, France
5Universidad de Navarra, Pamplona, Spain
6Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
7University Hospital Vall d’Hebron, Barcelona, Spain
8Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy
9Fondazione 'G. Pascale', IRCCS, Naples, Italy
10Hospital Universitario De Salamanca, IBSAL, Salamanca, Spain
11Fred Hutchinson Cancer Center, University of Washington, Seattle, WA
12Enterome, Paris, France
13University of Bologna, Bologna, Italy
14University of Rochester, Rochester, NY

Neha Akkad, MD1, Amy Ayers, MPH2*, Kumudha Balakrishnan, MPhil, MSc, PhD2*, Loretta Nastoupil2*, Dai Chihara, MD, PhD2, Luis Malpica, MD2*, Paolo Strati, MD2, Ziyi Li, PhD3* and Christopher R. Flowers, MD, MS2

1Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TT
2Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX

Maria Gavriatopoulou*, Ioannis Ntanasis-Stathopoulos, MD, PhD, MSc*, Vasiliki Spiliopoulou, MD*, Charalampos Filippatos*, Magdalini Migkou, MD*, Panagiotis Malandrakis, MD*, Foteini Theodorakakou, MD*, Nikolaos Kanellias*, Evangelos Eleutherakis-Papaiakovou, MD*, Despina Fotiou, MD*, Evangelos Terpos, MD, PhD, Meletios-Athanasios Dimopoulos and Efstathios Kastritis, MD, PhD*

Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

Daniel J. Landsburg, MD1, Richard T. Maziarz, MD2, Amy Moskop, MD3, Leslie L. Popplewell, MD, MPH4, Scott R. Solomon, MD5, Michael T. Tees, MD, MPH6, Yongzi Yu, MS7*, Aiesha Zia, MSc8*, Stephen Lim, MD9*, Avishek Pal, MSc8*, Pei Hsu, MD8* and Frederick Locke, MD10

1Department of Medicine, University of Pennsylvania, Philadelphia, PA
2Knight Cancer Institute, Oregon Health and Science University, Portland, OR
3Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI
4Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Atlanta, GA
5Northside Hospital Cancer Institute, Atlanta, GA
6Colorado Blood Cancer Institute, Denver, CO
7Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
8Novartis Pharma AG, Basel, Switzerland
9Novartis Pharmaceuticals Corporation, East Hanover, NJ
10Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL

Lin Shen1*, Jing Bao2*, Lihong Shou3*, Ying Lu4*, Qi Zhu5*, Li Wang, MD6* and Weili Zhao6

1Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China
2Department of Hematology, The First Affiliated Hospital of Anhui Medical University, Hefei, China
3Department of Hematology, Huzhou Central Hospital, The Fifth School of Clinical Medicine of Zhejiang Chinese Medical University, Huzhou, China
4Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, China
5Department of Oral and Maxillofacial-Head and Neck Oncology, Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai, China
6Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China

Marzia Varettoni1*, Emilia Cappello, MD2*, Emanuela Boveri3*, Virginia Valeria Ferretti4*, Silvia Zibellini1*, Gianmarco Favrin2*, Chiara Varraso1*, Marco Lucioni3*, Cristina Picone1*, Giulia Vittoria Facchetti2*, Giovanni O. Palladini, MD, PhD2,5, Marco Paulli, MD3,6* and Luca Arcaini1,2*

1Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
2Department of Molecular Medicine, University of Pavia, Pavia, Italy
3Pathology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
4Unit of Biostatistics and Clinical Trial Center, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy
5Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
6University of Pavia, Pavia, Italy

José Antonio Sánchez Salas, MD1*, Estela Ruiz Ruiz, MD2*, Almudena Cascales Hernandez, MD2*, Joaquin Gomez Espuch, MD, PhD3*, Andrea Poveda Garcia, MD2*, Angela Heredia Cano, MD2*, Miguel Blanquer Blanquer, MD, PhD4, Maria Carmen GARCIA Garay, MD3*, Antonio Jose Martinez Mellado2*, Alfredo Minguela Puras, PhD5*, Agueda Bas Bernal, MD6*, Vanessa Roldan Schilling, MD, PhD2* and Antonio Salar Silvestre, MD, PhD7*

1Hematology, Virgen de la Arrixaca University Hospital, Murcia (Spain), Guadix, Spain
2Hematology, Virgen de la Arrixaca University Hospital, Murcia (Spain), El Palmar, Murcia, Spain
3Hematology, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain
4Hematology, Hospital Clínico Universitario Virgen De La Arrixaca, Murcia, Spain
5Immunology, Virgen de la Arrixaca University Hospital, Murcia (Spain), El Palmar, Murcia, Spain
6Pathology, Virgen de la Arrixaca University Hospital, Murcia (Spain), El Palmar, Murcia, Spain
7Hematology, Virgen de la Arrixaca University Hospital, Murcia (Spain), Murcia, Spain

Kriti Ahuja1 and Arya Mariam Roy, MD2,3

1Roswell Park Comprehensive Cancer Center, Chicago, IL
2Ohio State University/ The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH
3Rosewell Park Cancer Center, Buffalo, NY

Ana Marin Niebla, MD PhD1*, Mariana Bastos-Oreiro2*, Amanda Isabel Perez, MD3*, Alba Cabirta Touzón, MD4*, Fatima De la Cruz Vicente, MD5*, Marta Canelo6*, Ana Jiménez Ubieto7*, Sonia González De Villambrosia8*, Ana Muntañola9*, Hugo Daniel Luzardo Henríquez10*, Eduardo Rios Herranz, MD11*, Pilar Gómez12*, Alberto López, MD13*, Ana Saus Carreres14*, Alejandro Martín García-Sancho15*, Ana Garcia Noblejas16*, Carlos Grande17*, Pablo Prieto Martinez, MD18*, Concepción Nicolás19*, Antonio Gutierrez, MD, PhD20*, Jose-Angel Hernandez Rivas, MD, PhD21*, Blanca Sánchez González22*, Rosalia Alonso Trillo, MD23*, Eva Donato24*, Paola Villafuerte Gutiérrez25*, Daniel García Belmonte26*, Silvia Rocio Verdesoto Cozzarelli27*, Sandra Suarez Ordoñez, MD28*, Emilia Pardal De La Mano29*, Lucia Villalon Blanco30*, Alicia Roldán-Pérez31*, Eva Gine, MD32, Juan-Manuel Sancho, MD, PhD33*, Raul Cordoba, MD, PhD34, Beatriz De La Cruz35*, Victor Navarro Garces, BSc36* and Pau Abrisqueta, MD PhD37

1Hematology Department, Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron, Barcelona, Spain
2Hematology Department, General University Hospital Gregorio Marañón, Madrid, Spain
3Hematology Department, Hospital Clinic de Barcelona, ICMHO, Barcelona, Spain
4Hematology Department, Vall d'Hebron Institute of Oncology (VHIO), University Hospital Vall d'Hebron, Barcelona, Spain
5Instituto de Biomedicina de Sevilla (IBIS)/CSIC/Universidad de Sevilla, University Hospital Virgen del Rocío, Seville, Spain
6Hematology Department, Hospital Universitario Germans Trias i Pujol, Badalona, Barcelona, Spain
7Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain
8Hematology Department, Hospital Universitario Marqués de Valdecilla (IDIVAL), Santander, Spain
9Hematology Department, Hospital Santa Creu i Sant Pau, Barcelona, Spain
10Hematology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain
11Hematology Department, University Hospital Ntra. Sra de Valme, Seville, Spain
12Hospital La Paz, Madrid, Spain
13Hematology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
14Hematology Department, Hospital Clínico de Valencia, Valencia, Spain
15Hospital Universitario de Salamanca, IBSAL, CIBERONC, Universidad de Salamanca, Salamanca, Spain
16Hospital Universitario la Princesa, Madrid, ESP
17Hematology Department, Clínica Universidad de Navarra, Madrid, Spain
18Hematology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain
19Hematology Department, Hospital Universitario Central de Asturias, Oviedo, Spain
20Hematology Department, Hospital Universitario Son Espases, IdISBa, Palma de Mallorca, Spain
21Hospital Universitario Infanta Leonor, Universidad Complutense, Madrid, Spain
22Hematology Department, Hospital del Mar, Barcelona, Spain
23Hematology Department, Hospital Universitario de Getafe, Madrid, Spain
24Hematology Department, Hospital Universitario Doctor Peset, Valencia, Spain
25Hematology Department, Hospital Universitario Principe de Asturias, Madrid, Spain
26Hematology Department, Hospital Universitario La Zarzuela, Madrid, Spain
27Hematololgy Department, Hospital de San Juan Despí Moisès Broggi, Barcelona, ESP
28Hematology Department, Complejo Hospitalario de Vigo, Vigo, Spain
29Hematology Department, Hospital Virgen del Puerto, Plasencia, Cáceres, Spain
30Hospital Universitario Fundación Alcorcón, Alcorc N, Madrid, ESP
31Hematology Department, Hospital Universitario Infanta Sofía, Madrid, Spain
32Department of Hematology, ICAMS, Hospital Clínic de Barcelona, Barcelona, Spain
33ICO-IJC-Hospital Germans Trias i Pujol, Barcelona, Spain
34Hematology, University Hospital Fundación Jiménez Díaz, Madrid, Spain
35Hematology Department, Hospital Universitario La Paz, Madrid, Spain
36Statistics Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
37Department of Hematology, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron University Hospital, Barcelona, Spain

Jorge J. Castillo, MD1, Steven P. Treon, MD, PhD, FRCP2, Catherine A. Flynn, NP1*, Andres Ramirez-Gamero, MD1*, Nina S Budano1*, Alexandra N. Eurell1*, Kirsten Meid, MPH1* and Shayna R Sarosiek1

1Dana-Farber Cancer Institute, Bing Center for Waldenström Macroglobulinemia, Boston, MA
2Dana-Farber Cancer Institute, Dana-Farber Cancer Institute, Inc., Boston, MA

Ingrid Glimelius, MD, PhD1,2, Won Seog Kim3*, Ewa Paszkiewicz-Kozik, MD, PhD4*, Daniel Ernst, MD5, Reid W. Merryman, MD6, Claudia Moreira7*, Sanfang Tu8*, Yixin Ren9*, Katherine Ryland, PhD9, Uzor C. Ogbu, MBBS, PhD9 and Pier Luigi Zinzani, MD, PhD10,11

1Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
2Akademiska sjukhuset-Blod-och tumorsjukdomar, Uppsala, Sweden
3Samsung Medical Center, Seoul, Korea, Republic of (South)
4Maria Sklodowska–Curie National Research Institute of Oncology, Warsaw, Poland
5Servicio de Hematología, Clínica Alemana de Santiago, Santiago, Chile
6Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
7Instituto Português de Oncologia do Porto Francisco Gentil Epe, Porto, Portugal
8Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China
9Merck & Co., Inc., Rahway, NJ
10IRCCS Azienda Ospedaliero-Universitaria di Bologna  Istituto di Ematologia “Seràgnoli”, Bologna, Italy
11Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy

Jie Wang, MD, MS1, Jihao Zhou, MD, PhD2*, Yucai Wang, MD, PhD3, Javier L. Munoz, MD, MS, MBA4, Kevin G. Shim3*, Muhamad Alhaj Moustafa, M.D., M.S.5, Firas Baidoun, MD6, Kaitlin Annunzio, DO7, Narendranath Epperla, MD MS7, Michael McLane, MD8, Yasmin H. Karimi, MD8, Binh Luu, BS9*, Stephen E Spurgeon, MD9, Cheryl Chang, BA10*, Zihan Wan, MS11*, Diamone Gathers, MD12*, Emily R. King, BA13*, Marcus P. Watkins, PhD14*, Nancy L. Bartlett, MD13, Christine E. Ryan, MD15, Genevieve M Gerhard, MD16, Philippe Armand, MD, PhD17, Ann S. LaCasce, MD, MMSc18, Vedha Vaddaraju19*, Danielle S Wallace, MD20, Vaishalee P Kenkre, MD21, Chase Junge, MD21*, Natalie Grover, MD22, Jorge A Florindez, MD23, Reem Karmali, MD24, Alexander V. Stanisic, MD25*, Chen Zhang, MD, MS26*, Parameswaran Venugopal, MD26, Grace Ying, DO27*, Caitlin Gribbin, MD, MS28, Jia Ruan, MD, PhD29, Navika D Shukla, MD30, Sonali M. Smith, MD31, Viktoriya Zelikson, MD32, Michael E. Williams, MD ScM32, Stefan K. Barta, MD33, Omar Elghawy, MD34*, Jake Schade, BA35*, Rohini Navalekar, MPA36*, Matthew Matasar, MD, MS37, Andrew M Evens, DO MBA MSc35, Alexey V. Danilov, MD, PhD38 and Timothy S. Fenske, MD39

1Duke Cancer Institute, Hillsborough, NC
2Division of Hematology, Mayo Clinic, Rochester, MN
3Mayo Clinic, Rochester, MN
4Mayo Clinic Arizona, Phoenix, AZ
5Division of Hematology, Mayo Clinic, Jacksonville, FL
6Mayo Clinic, Jacksonville, FL
7Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH
8Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI
9Knight Cancer Institute, Oregon Health & Science University, Portland, OR
10Duke University School of Medicine, Durham, NC
11Duke Cancer Institute, Durham, NC
12Duke Cancer Institute, Durham
13Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
14Division of Oncology, Washington University School of Medicine, St. Louis, MO
15Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
16Beth Israel Deaconess Medical Center, Boston, MA
17Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA
18Dana-Farber Cancer Institute, Boston, MA
19Wilmot Cancer Insititute, University of Rochester Medical Center, Rochester, NY
20Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY
21University of Wisconsin School of Medicine and Public Health, Madison, WI
22University of North Carolina, Chapel Hill, NC
23Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
24Northwestern University Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL
25Northwestern University Feinberg School of Medicine, Chicago, IL
26Rush University Medical Center, Chicago, IL
27Medical College of Wisconsin, Milwawkee, WI
28Weill Cornell Medicine, New York, NY
29Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY
30Department of Medicine, University of Chicago, Chicago, IL
31University of Chicago, Chicago, IL
32University of Virginia Comprehensive Cancer Center, Charlottesville, VA
33Abramson Cancer Center, The Fox Chase Cancer Center Foundation, Philadelphia, PA
34Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
35Rutgers Cancer Institute, New Brunswick, NJ
36Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
37Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ
38City of Hope National Medical Center, La Canada Flintridge, CA
39Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI

Mazyar Shadman1, Nancy L. Bartlett, MD2, Matthew Matasar, MD, MS3, Stephen J. Schuster4*, Sarit E. Assouline, MD5, Laurie H. H. Sehn, MD6, John Kuruvilla, MD, FRCPC7, Pratyush Giri, MBBS8*, Chan Y. Cheah, MBBS DMSc9, Sascha Dietrich10*, Keith Fay11*, Matthew Ku, MBBS, PhD12*, Loretta Nastoupil13*, Michael C. Wei14*, Shen Yin14*, Connie Y. Ma14*, Samuel Tracy14*, Antonia Kwan14*, Elicia Penuel14* and L. Elizabeth Budde15

1Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA
2Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
3Memorial Sloan Kettering Cancer Center, New York, NY
4Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
5Jewish General Hospital, Montreal, QC, Canada
6BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, BC, Canada
7Princess Margaret Cancer Centre, Toronto, ON, Canada
8Royal Adelaide Hospital, Adelaide, Australia
9Sir Charles Gairdner Hospital, Linear Clinical Research and the University of Western Australia, Perth, Australia
10Universitat Heidelberg, Heidelberg, Germany
11St Vincent's Hospital and Royal North Shore Hospital, Sydney, Australia
12St Vincent's Hospital, University of Melbourne, Melbourne, Australia
13MD Anderson Cancer Center, Houston, TX
14Genentech, Inc., South San Francisco, CA
15City of Hope National Medical Center, Duarte, CA

Austin I. Kim, MD1, Philippe Armand, MD, PhD2, Christine E. Ryan, MD2, Robert A. Redd, MS3*, Megan Forsyth2*, Juniper Mai2*, Samantha Pazienza, BS2*, Caitlin Bresnahan2*, Vanessa M Kats2*, Salah Abdulkarim2*, Susan M Waisgerber, ANP2*, Reid W. Merryman, MD2, David C. Fisher, MD2, Inhye E. Ahn, MD2, Jennifer L. Crombie, MD2, Oreofe O. Odejide, MD2, Ann S. LaCasce, MD, MMSc1, Caron A. Jacobson, MD, MMSc2, Eric D. Jacobsen, MD1, Erin M. Parry, MD, PhD2, David A. Qualls, MD2, Amy C. Bessnow, MD, MPH1*, Matthew S. Davids, MD, MMSc4, Jennifer R. Brown, MD, PhD2, Jon E. Arnason, MD5, Michael Leukam, MD5*, Peter A. Riedell, MD6 and Mark A. Murakami, MD2

1Dana-Farber Cancer Institute, Boston, MA
2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
3Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
4Department of Medical Oncology, Dana-Farber Cancer Institute, Inc., Boston, MA
5Beth Israel Deaconess Medical Center, Boston, MA
6Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL

Christine E. Ryan, MD1, Imran A. Nizamuddin, MD2, Hari S. Raman, MD3*, Robert A. Redd, MS4*, Marcus P. Watkins, PhD2*, Ann S. LaCasce, MD, MMSc1, David C. Fisher, MD3, Austin I. Kim, MD3, Matthew S. Davids, MD, MMSc3, Caron A. Jacobson, MD, MMSc3, Oreofe O. Odejide, MD3, Jennifer L. Crombie, MD3, Neha Mehta-Shah, MD2, Amanda F. Cashen, MD2, Armin Ghobadi, MD2, Nancy L. Bartlett, MD2, Eric D. Jacobsen, MD1, Philippe Armand, MD, PhD3, Brad S. Kahl, MD5 and Reid W. Merryman, MD3

1Dana-Farber Cancer Institute, Boston, MA
2Division of Oncology, Washington University School of Medicine, St. Louis, MO
3Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
4Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
5Washington University School of Medicine, Saint Louis, MO

Chan Y. Cheah, MBBS DMSc1, Amanda Jane Johnston, MBBS, MD2, Joel Wight, MBBS, FRACP, FRCPA, DMedSc3*, Piers Blombery, MBBS4, Katharine L. Lewis5, Rory Bennett, MBChB6*, Jing Xie, PhD7*, Stella Vlahos8*, Joyce Gonzales, MD9*, Sally Binks10* and John F. Seymour, MBBS, PhD6

1Sir Charles Gairdner Hospital, Perth, Western Australia, Australia
2Westmead Hospital, Westmead, NSW, AUS
3Department of Haematology & Bone Marrow Transplantation, Townsville University Hospital, Townsville, Australia
4Peter Maccallum Cancer Centre, East Melbourne, VIC, Australia
5Sir Charles Gairdner Hospital, West Leederville, Australia
6Department of Clinical Haematology, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
7Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
8Centre for Biostatistics and Clinical Trials, Melbourne, Australia
9Parkville Cancer Clinical Trials Unit, Peter MacCallum Cancer Centre, Victoria, Australia
10Sir Charles Gairdner Hospital, Perth, Australia

Elizabeth Brem, MD1, Wojciech Jurczak, MD, PhD2, David Belada3, Jaime Perez de Oteyza4*, Aranzazu Alonso Alonso, MD5*, Fevzi Altuntas, MD6*, Michał Kwiatek7*, Joshua Brody8*, Ernesto Perez Persona9*, Mustafa Yenerel10*, Monica Tani11*, Jingxian Cai12*, Priya Deshpande12*, Saleem Shariff13*, Aafia Chaudhry12, Hesham Mohamed12, Srikanth Ambati12, Ashish Risal12* and Ruemu Birhiray14

1University of California, Irvine, Orange, CA
2Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Malopolskie, Poland
3University Hospital and Faculty of Medicine, Hradec Králové, Czech Republic
4Universidad CEU San Pablo, Madrid, Spain
5Hospital Universitario Quirónsalud Madrid, Madrid, Spain
6Ankara Oncology Training and Research Hospital, Ankara, Turkey
7Aidport Clinical Trials Hospital, Skorzewo, Poland
8Icahn School of Medicine at Mount Sinai, New York, NY
9Hospital Universitario de Navarra, Pamplona, Spain
10Istanbul University, Istanbul, Turkey
11Santa Maria delle Croci Hospital, Ravenna, Italy
12Regeneron Pharmaceuticals, Inc., Tarrytown, NY
13Regeneron UK Ltd, Uxbridge, United Kingdom
14Hematology Oncology of Indiana/American Oncology Network, Indianapolis, IN

Judith Trotman, FRACP1, Katherine Rankin, MBBS2*, Ibrahim Tohidi-Esfahani, MBBS, FRACP, FRCPA1, Alessandra Tedeschi, MD3*, Constantine S. Tam, MD, MBBS4, Christian Buske, MD5, Roger G Owen, MD, MRCP, FRCPath6*, Veronique LeBlond, MD7*, Meletios A. Dimopoulos, MD8, Peter Smallwood9*, Heather Allewelt, MD10*, Wai Y Chan10*, Radha Prathikanti, MPH, MBA10*, Jingjing Schneider10*, Remus Vezan, MD, PhD10* and Stephen S. Opat, MBBS, FRACP, FRCPA11

1Concord Repatriation General Hospital, University of Sydney, Concord, NSW, Australia
2Calvary Mater Newcastle Hospital, Waratah, NSW, Australia
3ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
4Alfred Hospital and Monash University, Melbourne, VIC, Australia
5Institute of Experimental Cancer Research, Comprehensive Cancer Center Ulm, University Hospital Ulm, Ulm, Germany
6St. James’s University Hospital, Leeds, United Kingdom
7Sorbonne University, Pitié Salpêtrière Hospital, Paris, France
8National and Kapodistrian University of Athens, School of Medicine, Alexandra Hospital, Athens, Greece
9Patient author, Concord Repatriation General Hospital, University of Sydney, Concord, NSW, Australia
10BeiGene USA, Inc, San Mateo, CA
11Lymphoma Research Group, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia

Lara Gallucci Figorelle, MD1*, Renata Lyrio R Baptista, MD2*, Flavia Dias Xavier, MD3*, Peterson Tiago Galvao, MD1*, Cristiane Milito4*, Ruddy Dalfeor, MD5*, Mariana Guarana, MD6*, Katia Carneiro, PhD7*, Bruna Souza Sabioni, MD8*, Luana Brito1*, Patricia Souza Marimon9*, Sergio Augusto B Brasil, MD, PhD10,11*, Celso Arrais-Rodrigues, MD, PhD12, Verena Pfister13,14*, Vitoria Siqueira15*, Rafaella C. Samico16*, Valeria Vianna, MSc17* and Rony Schaffel, MD, PhD18

1Hospital Universitário Clementino Fraga Filho - Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
2State University of Rio de Janeiro, Rio De Janeiro, Brazil
3Universidade Federal de Brasilia, BRASILA / DF - BRAZIL, BRA
4Hospital Universitario Clementino Fraga Filho, Petropolis, BRA
5Hospital Universitario Clementino Fraga Filho, Rio de Janeiro, Brazil
6Hospital de Clínicas Gafree e Guinle, Rio de Janeiro, Brazil
7Universidade Federal do Rio de Janeiro, Rio De Janeiro, BRA
8Estrada Teresopolis Itaipava, Teresopolis, BRA
9Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
10Hospital Santa Paula. São Paulo – Brazil, Sao Paulo, Brazil
11Santa Casa Medical School of Sao Paulo, Sao Paulo, Brazil
12Hospital Nove de Julho, DASA, São Paulo, Brazil
13Division of Hematology - UNIFESP, Sao Paulo, AC, Brazil
14Hospital 9 de Julho, São Paulo, Brazil
15Hospital Ophir Loyola, Belem, Brazil
16Hospital do Cancer de Muriaé, Muriaé, Minas Gerais, BRA
17Hospital Universitário Clementino Fraga Filho - Universidade Federal do Rio de Janeiro, Rio De Janeiro, AL, Brazil
18HUCFF / UFRJ, Rio de Janeiro, Brazil

David A Russler-Germain, MD, PhD1, Fei Wan, PhD2*, Emily R. King, BA3*, Chaz Moreno3*, Michelle Becker-Hapak4*, Patrick Pence4*, Joseph Rueve4*, Sushanth A Pureti4*, Dilan A. Patel, MD3*, Brad S. Kahl, MD5, Neha Mehta-Shah, MD6, Todd A Fehniger7 and Nancy L. Bartlett, MD3

1Siteman Cancer Center, Division of Oncology, Washington University School of Medicine, Saint Louis, MO
2Division of Public Health Sciences, Washington University School of Medicine, St. Louis, MO
3Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
4Division of Oncology, Washington University School of Medicine, St. Louis, MO
5Department of Medicine, Washington University School of Medicine, St. Louis, MO
6Siteman Cancer Center, Washington University School of Medicine, Olivette, MO
7Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO

Vaishalee P Kenkre, MD1, Yong Lin2*, Narendranath Epperla, MD, MS3,4, Saurabh A Rajguru, MD5*, Julie E Chang, MD6,7, Priyanka A. Pophali, MD8, Elyse I Harris, MD9*, Christopher D Fletcher, MD5*, Matthew Matasar, MD, MS10, Hussam Eltoukhy, MD11, David A. Bond, MD, BS12,13, Yazeed Sawalha, MD12, Beth Christian, MD12, Timothy Voorhees, MD, MSc12, Mariah Endres14*, Mitch Howard14*, Damayanti Bhavsar15*, Misty Fleming16*, Jordan S. Carter, MD17 and Andrew M Evens, DO MBA MSc18

1University of Wisconsin School of Medicine and Public Health, Madison, WI
2Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
3Ohio State University, Columbus, OH
4The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH
5Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI
6University of Wisconsin, Madison, WI
7Department of Medicine, University of Wisconsin, Madison, WI
8Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI
9Carbone Cancer Center, University of Wisconsin–Madison, Madison, WI
10Division of Blood Disorders, Rutgers Cancer Institute of New Jersey and RWJBarnabas Health, New York, NY
11Rutgers New Jersey Medical School, New Brunswick, NJ
12Division of Hematology, The Ohio State University, Columbus, OH
13The James Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH
14University of Wisconsin Carbone Cancer Center, Madison, WI
15Rutgers, Cancer Institute of New Jersey, New Brunswick, NJ
16Ohio State University James Cancer Center, Columbus, OH
17Hospital of the University of Pennsylvania, Philadelphia, PA
18Rutgers Cancer Institute, New Brunswick, NJ

Luani Barge, MChD, FRACP, FRCPA1,2,3*, Joshua W.D. Tobin, MD, PhD1,3*, Niamh Waters, MBBS4*, Ross Salvaris, MBBS5*, Sam Lai, MBBS6*, Tessa Potezny, MBBS7*, Helen Cashman, MBBS8*, Caitlyn Nguyen-Ngo, MBBS, PhD9*, Denise Lee, MBBS4,10*, Costas K. Yannakou, MBBS, PhD11*, Nada Hamad, MBBS, MSc, BSc8,12,13, Constantine S. Tam, MBBS, MD7,14, Abir Bhattacharyya, MBBS6, Chan Y. Cheah, MBBS DMSc5, Kirk Morris, MBBS, FRACP, FRCPA2, Eliza A. Hawkes, MD4 and Greg Hapgood, MD, PhD, FRACP, FRCPA1,3*

1Princess Alexandra Hospital, Brisbane, QLD, Australia
2Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia
3University of Queensland, Brisbane, QLD, Australia
4Austin Hospital, Melbourne, VIC, Australia
5Sir Charles Gairdner Hospital, Perth, Western Australia, Australia
6Westmead Hospital, Sydney, NSW, Australia
7Alfred Hospital, Melbourne, VIC, Australia
8St Vincent's Hospital, Sydney, NSW, Australia
9Epworth HealthCare, Melbourne, VIC, Australia
10Boxhill Hospital, Melbourne, VIC, Australia
11Molecular Oncology and Cancer Immunology, Epworth HealthCare, Melbourne, VIC, Australia
12The University of New South Wales, Kensington, NSW, Australia
13School of Medicine, University of Notre Dame, Sydney, Australia
14Monash University, Melbourne, VIC, Australia

Lu Zhang, MD1*, Qinhua Liu2*, Hui Zhou3*, Huilai Zhang, MD4, Yujun Dong5*, Xiaobo Wang6*, Luqun Wang7*, Liping Su8, Xiaojing Yan, MD, PhD9, Yan Li10*, Mingzhi Zhang, MD11, Kaiyang Ding12*, Hui-Han Wang13*, Hongling Peng, MD14*, Liye Zhong, MD, PhD15*, Lin Yang16*, Lintao Bi, MD, PhD17, Da Gao, MD18*, Guangxun Gao, MD19*, Liang Huang20, Chunyan Sun21*, Jia Song, MD22*, Wenbin Qian23, Wenrong Huang24, Zhenling Li25*, Yao Liu26* and Jian Li, MD1

1Department of Hematology, Peking Union Medical College Hospital, Beijing, China
2Department of Hematology, the First Affiliated Hospital of Anhui Medical University, Hefei, China
3Hunan Cancer Hospital, Changsha, China
4Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China
5Department of Hematology, Peking University First Hospital, Beijing, CHN
6The Second Hospital of Dalian Medical University, Dalian, China
7Qilu Hospital of Shandong University, Shandong, China
8Shanxi Province Cancer Hospital, Taiyuan, China
9Department of Hematology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China
10Department of Hematology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, CHN
11The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
12Department of Hematology, The First Affiliated Hospital of USTC, Hefei, CHN
13Shengjing Hospital of China Medical University, Shenyang, CHN
14Department of hematology, The second xiangya hospital of Central South University, Changsha, China
15Guangdong Provinal People's Hospital, Guangzhou, China
16The Second Hospital of Hebe Medical University, Shijiazhuang, Hebei, China, Shijiazhuang, CHN
17Department of Hematology, China-Japan Union Hospital of Jilin University, Changchun, AL, China
18The affiliated hospital of inner mongolia medical univuniversity, Hohhot, China
19Department of Hematology, Xijing Hospital, Xi’An, China
20Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
21Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
22Department of Hematology, Tianjin Medical University General Hospital, Tianjin, China
23Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
24Lymphoma & Plasma Cell Disease Department of Hematology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, China
25China-Japan Friendship Hospital, Beijing, China
26Chongqing University Cancer Hospital, Chongqing, China

Xin Li1*, Jia Wei2, Dong-feng Zeng3*, Shu-nan Qi4*, Bingzong Li, MD, PhD5, Wei Guo, MD/PhD6*, Li Wang7*, Yajun Li, MD8*, Xudong Zhang, (M.D.)Dr.9*, Yong Yang, MD10*, Shukai Qiao11*, Yan Zeng3*, Yunfei Song12*, Jing-wen Wang1*, Jian-min Ma1* and Liang Wang13*

1Beijing Tongren Hospital, Beijing, China
2Tongji Hospital, Tongji Medical College, Huazhong University of Science and Tech, Wuhan, Hubei, China
3Daping Hospital, Army Medical University, Chongqing, China
4National Cancer Center/ National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China
5Department of Hematology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
6Department of Hematology, The First Hospital of Jilin University, Changchun, China
7Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
8Hunan Cancer Hospital, Changsha, China
9The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
10Fujian Medical University Union Hospital, Fuzhou, China
11Hebei Medical University Second Hospital, Shijiazhuang, Hebei, China., Shijiazhuang, China
12Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
13Beijing Tongren Hospital, Guangzhou, China

Sarah Matarasso Greenfeld, MD1*, Ian Shrier, MD, PhD, Dip Sport Med, FACSM2* and Sarit E. Assouline, MD1

1Jewish General Hospital, McGill University, Montreal, QC, Canada
2Senior Investigator Emeritus, Centre for Clinical Epidemiology, Lady Davis Institute, Montreal, QC, Canada

Kriti Ahuja1 and Arya Mariam Roy, MD2,3

1Roswell Park Comprehensive Cancer Center, Chicago, IL
2Ohio State University/ The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH
3Rosewell Park Cancer Center, Buffalo, NY

Geoffrey Shouse, PhD, DO1, Shin Yeu Ong, MD, FRCPath2*, Max J Gordon, MD3*, Tanya Siddiqi, MD4 and Alexey V. Danilov, MD, PhD5

1City of Hope National Medical Center, Duarte, CA
2Singapore General Hospital, Singapore, Singapore
3Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
4Department of Hematology, City of Hope, Irvine, CA
5City of Hope National Medical Center, La Canada Flintridge, CA

Ana Marin Niebla, MD PhD1*, Mariana Bastos-Oreiro2*, Amanda Isabel Perez, MD3*, Alba Cabirta Touzón, MD4*, Fatima De la Cruz Vicente, MD5*, Marta Canelo6*, Ana Jiménez Ubieto7*, Sonia González De Villambrosia8*, Ana Muntañola9,10*, Hugo Daniel Luzardo Henríquez11*, Eduardo Rios Herranz, MD12*, Beatriz De La Cruz13*, Raul Cordoba, MD, PhD14, Ana Saus Carreres15*, Alejandro Martín García-Sancho16*, Ana Garcia Noblejas, MD, PhD17*, Carlos Grande18*, Pablo Prieto Martinez, MD19*, Concepción Nicolás20*, Antonio Gutierrez, MD, PhD21*, Jose-Angel Hernandez Rivas, MD, PhD22*, Blanca Sánchez-González23*, Rosalia Alonso Trillo, MD24*, Eva Donato25*, Paola Villafuerte Gutiérrez26*, Daniel García Belmonte27*, Silvia Rocio Verdesoto Cozzarelli28*, Sandra Suarez Ordoñez, MD29*, Emilia Pardal De La Mano30*, Lucia Villalon Blanco31*, Eva Gine, MD32, Juan-Manuel Sancho, MD, PhD33*, Alberto Lopez Garcia, MD34, Alicia Roldán-Pérez35*, Pilar Gómez36*, Victor Navarro Garces, BSc37* and Pau Abrisqueta, MD PhD38

1Hematology Department, Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron, Barcelona, Spain
2Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
3Department of Hematology, ICAMS, Hospital Clínic de Barcelona, Barcelona, Spain., Barcelona, Spain
4Hematology Department, Vall d'Hebron Institute of Oncology (VHIO), University Hospital Vall d'Hebron, Barcelona, Spain
5Instituto de Biomedicina de Sevilla (IBIS)/CSIC/Universidad de Sevilla, University Hospital Virgen del Rocío, Seville, Spain
6Hematology Department, Hospital Universitario Germans Trias i Pujol, Badalona, Barcelona, Spain
7Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain
8Hematology Department, Hospital Universitario Marqués de Valdecilla (IDIVAL), Santander, Spain
9MúTua Terrassa, Terrassa University Hospital, Terrassa, ESP
10Hematology Department, Hospital Santa Creu i Sant Pau, Barcelona, Spain
11Hematology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain
12Hematology Department, University Hospital Ntra. Sra de Valme, Seville, Spain
13Hematology Department, Hospital Universitario La Paz, Madrid, Spain
14Hematology Department, Health Research Institute IIS-FJD, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
15Hematology Department, Hospital Clínico de Valencia, Valencia, Spain
16Hematology Department, Salamanca University Hospital, IBSAL, CIBERONC, Salamanca, Spain
17Hematology Department, Hospital Universitario La Princesa, Madrid, Spain
18Hematology Department, Clínica Universidad de Navarra, Madrid, Spain
19Hematology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain
20Hematology Department, Hospital Universitario Central de Asturias, Oviedo, Spain
21Hematology Department, Son Espases University Hospital, IdISBa, Palma, Spain
22Hospital Universitario Infanta Leonor, Universidad Complutense, Madrid, Spain
23Hematology Department, Hospital del Mar, Barcelona, Spain
24Hematology Department, Hospital Universitario de Getafe, Madrid, Spain
25Hematology Department, Hospital Universitario Doctor Peset, Valencia, Spain
26Hematology Department, Hospital Universitario Principe de Asturias, Madrid, Spain
27Hematology Department, Hospital Universitario la Zarzuela, Madrid, Spain
28Hematololgy Department, Hospital de San Juan Despí Moisès Broggi, Barcelona, ESP
29Hematology Department, Complejo Hospitalario de Vigo, Vigo, Spain
30Hematology Department, Hospital Virgen del Puerto, Plasencia, Cáceres, Spain
31Hospital Universitario Fundación Alcorcón, Alcorc N, Madrid, ESP
32Department of Hematology, ICAMS, Hospital Clínic de Barcelona, Barcelona, Spain
33Clinical Hematology Department, ICO-IJC-Hospital Germans Trias i Pujol, Badalona, Spain
34Fundacion Jimenez Diaz University Hospital, Madrid, Spain
35Hematology Department, Hospital Universitario Infanta Sofía, Madrid, Spain
36Hospital La Paz, Madrid, Spain
37Statistics Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
38Department of Hematology, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron University Hospital, Barcelona, Spain

*signifies non-member of ASH